Table 3 Comparison of rheumatoid arthritis patients with regard to waist circumference (NCEP)
Variable | Normal WC n = 488 (100.0%) | Increased WC n = 250 (100.0%) | Total n = 767 (100%) | p-value |
|---|---|---|---|---|
Female sex (n; %) | 442 (93.2) | 225 (78.1) | 667 (86.9) | 0.082 |
Non-white race/color (n; %) | 195 (41.1) | 109 (37.8) | 304 (39.6) | 0.111 |
Age (mean ± SD) | 52.8 ± 12.6 | 58.4 ± 12.0) | 57 ± 12.0 | < 0.001 |
Disease duration (mean ± SD) | 12.9 ± 9.2 | 12.7 ± 8.2 | 12.8 ± 8.9 | 0.866 |
Diabetes mellitus (n; %) | 27 (5.6) | 89 (30.9) | 116 (15.1) | < 0.001 |
Systemic arterial hypertension (n; %) | 172 (36.2) | 209 (72.5) | 381 (49.6) | < 0.001 |
Dyslipidemia (n; %) | 122 (25.7) | 134 (46.5) | 256 (33.3) | < 0.001 |
Family history of CVD (n; %) | 81 (17.1) | 47 (16.3) | 128 (16.7) | 0.290 |
Smoking (n; %) | 66 (13.9) | 27 (9.3) | 93 (12.1) | 0.371 |
Use of methotrexate (n; %) | 350 (73.8) | 165 (57.3) | 515 (67.1) | 0.866 |
Use of prednisone (n; %) | 329 (69.4) | 149 (51.7) | 478 (62.3) | 0.212 |
Use of leflunomide (n; %) | 169 (34.6) | 99 (39.6) | 268 (34.9) | 0.060 |
C-reactive protein (mean ± SD) | 16.4 ± 42.7 | 28.3 ± 131.9 | 20.1 ± 82.1 | 0.087 |
Rheumatoid factor (n; %) | 353 (74.5) | 168 (58.3) | 521 (67.9) | 0.655 |
DAS28 (mean ± SD) | 3.98 ± 1.54 | 4.29 ± 1.50 | 4.08 ± 1.53 | 0.012 |